An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT05649748 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05649748
- Sponsor
- Insmed Incorporated
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-07
- Primary completion
- 2026-12-31
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.